“hepatitis-b” Archives

in
Entry Author Date Location
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs 09/28/20 Boston
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Arrowhead Pharma Shares Soar on Early Liver Data for RNAi Drug 09/16/20 Wisconsin
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months 04/06/20 San Francisco
Spring Bank Pharma Ends Hepatitis B Work After Death in Clinical Trial 01/29/20 Boston
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug 10/31/19 Boston
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Ionis Gets $25M From GSK for Experimental Hepatitis B Program 08/27/19 San Diego
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Hookipa’s IPO Raises $84M for Drugs to Reprogram the Immune System 04/18/19 New York
Precision Bio’s IPO Raises $126M for Pipeline of Gene-Edited Drugs 03/27/19 Raleigh Durham
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline 12/06/18 Raleigh Durham
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M 10/29/18 Boston
Janssen Reaches $250M Deal for Rights to Arrowhead’s Hep B RNAi Drug 10/04/18 Wisconsin
Gilead Partners with Precision Bio in Search of Gene-Editing HBV Cure 09/12/18 San Francisco
Arrowhead Shares Pop on Early Clinical Data for Hepatitis B Drug 09/06/18 Wisconsin
Exact Sciences, Mayo Clinic Share Data on DNA-Based Liver Cancer Test 06/06/18 Wisconsin
Shine, BrightStar, Understory & More: This Week’s WI Watchlist 02/20/18 Wisconsin
Arrowhead Plans Return to Clinic With New Study of Hep B Drug 02/16/18 Wisconsin
Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist 12/08/17 Wisconsin
Arrowhead Pharma Reveals Data It Hopes Will Aid New Hepatitis B Drug 12/06/17 Wisconsin
Dynavax Co-founder Takes Long View on Vaccine Development 12/05/17 San Diego
Scangos Heats Up Xconomy’s What’s Hot in Bay Area Biotech Lineup 11/02/17 San Francisco
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More 08/04/17 National
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Page 1 of 2 next page »